| abstract |
The invention provides a benzoheterocyclic derivative as a c-Met kinase inhibitor and its medical application. The benzoheterocyclic derivative of the c-Met kinase inhibitor has a structure of general formula (I). The compound involved in the invention has strong anti-tumor activity, can be used as a class of novel structure liver cancer treatment drug, and thus has good commercial value. I. |